NCT00147394View on ClinicalTrials.gov

Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

June 30, 2004

Conditions
Child Development Disorders, Pervasive
Interventions
DRUG

Risperidone

Trial Locations (5)

27705

Duke University Medical Center, Durham

45229

Cincinnati Children's Hospital, Cincinnati

48201

Children's Hospital of Michigan/Wayne State University, Detroit

44106-6010

Rainbow Babies and Children's Hospital, Cleveland

43210-1296

The Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT00147394 - Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD) | Biotech Hunter | Biotech Hunter